I thank my noble friend for his intervention. I was about to say that the existing UK legislation based on the current clinical trials directive will be corrected using the powers in this Bill so that that regime continues to function properly when the UK is no longer a member of the EU. This will mean that there is no interruption in UK clinical trials approval. Perhaps I may deal with the point raised by the noble Lord, Lord Kakkar.
European Union (Withdrawal) Bill
Proceeding contribution from
Baroness Goldie
(Conservative)
in the House of Lords on Monday, 12 March 2018.
It occurred during Committee of the Whole House (HL)
and
Debate on bills on European Union (Withdrawal) Bill.
About this proceeding contribution
Reference
789 c1338Session
2017-19Chamber / Committee
House of Lords chamberLibrarians' tools
Timestamp
2018-03-13 12:43:49 +0000
URI
http://hansard.intranet.data.parliament.uk/Lords/2018-03-12/18031212000126
In Indexing
http://indexing.parliament.uk/Content/Edit/1?uri=http://hansard.intranet.data.parliament.uk/Lords/2018-03-12/18031212000126
In Solr
https://search.parliament.uk/claw/solr/?id=http://hansard.intranet.data.parliament.uk/Lords/2018-03-12/18031212000126